Skip to content
Nahbal Pharma
Send an RFQ
For international manufacturers

A clearer route into Yemen’s healthcare market.

Start a scope-specific conversation around a product, opportunity or project support.

Send an RFQ
International manufacturers & suppliers

A clearer route into Yemen’s healthcare market.

Bring the product, portfolio or opportunity. Nahbal brings local context, institutional coordination and an evidence-led route to market discussion.

01

Institutional context

Frame the opportunity around buyer, facility, programme and tender requirements.

02

Technical route

Align specifications, documentation and manufacturer support to the stated scope.

03

Commercial coordination

Move from initial fit to a controlled quotation or project conversation.

04

Local follow-through

Coordinate the approved scope through supply, handover and business follow-up.

International manufacturers & suppliers

A clearer route into Yemen’s healthcare market.

Bring the product, portfolio or opportunity. Nahbal brings local context, institutional coordination and an evidence-led route to market discussion.

Discuss market entry
GLOBAL → YEMENLocal context. Clear scope. Documented execution.

Each relationship is described only to the level supported by commercial records, manufacturer documents or approved management confirmation.

A/01

BMV Technology Co. Ltd.

Manufacturer-authorized distributor · MX6 supply

A signed and stamped letter dated 25 August 2026 names Nahbal Pharma as an authorized distributor in Yemen for the stated tender submission and contract supply of 10 MX6 wireless convex ultrasound probe sets with compatible medical tablets.

Valid to 25 Aug 2027 · product/tender-specific · non-exclusive
A/02

Shanghai Drawell Scientific Instrument Co. Ltd.

Manufacturer-supported UNOPS opportunity

A project-specific authorization covers Nahbal Pharma’s representation for UNOPS RFQ/2026/62829, including offer submission, supply, warranty coordination and project support in Yemen if awarded.

Tender/support-period validity · no general or exclusive agency
A/03

Palintest (Middle East)

International supplier collaboration · water-analysis solutions

2026 commercial order, invoice and payment records document an active supply relationship for water-testing and disinfection-analysis systems. Nahbal Pharma management confirms that this relationship has supported successful water-analysis project delivery.

Commercial supply documented · project delivery confirmed by Nahbal management · no general agency or exclusivity claimed
A/04

U Square Lifescience Pvt. Ltd.

Product-scoped exclusive distribution · Yemen

A signed and authenticated 2026 agreement grants Nahbal Pharma distribution rights in Yemen for the pharmaceutical products listed in Annexure A. Exclusivity is limited to those products and remains subject to the agreement’s performance and termination provisions.

Stated term through 31 Dec 2030 · limited to Annexure A · not a general partnership
Start a business request

Tell us what healthcare needs. We’ll build the path to delivery.

Upload an RFQ or BOQ, build a multi-solution brief, or start a healthcare-project or manufacturer discussion. Business information only—never submit patient or health data.

Prefer a direct conversation?WhatsAppEmail
01
OrganizationBusiness contact details
02
RequirementArea, items and quantities
03
Delivery & filesContext needed for review
PDF, DOC, DOCX, XLS, XLSX or CSV · maximum 10 MB · no patient data · ZIP is disabled until malware scanning is enabled